Description
The race between infections and injections is in its most crucial phase. What life is like on the other side of the pandemic depends on three things: how well vaccines work, whether there are enough and how many people take them.
Michael Osterholm, an epidemiologist who has advised President Biden, tells us the world stands at an inflection point. After getting his jab in Jerusalem, our correspondent there says the vision of the future Israel offers other countries is not as rosy as it first seemed. James Fransham from The Economist data team unpicks the vaccination numbers so far.
Alok Jha, The Economist's science correspondent, hosts with our health policy editor, Natasha Loder. Edward Carr, The Economist's deputy editor, joins them.
For full access to The Economist’s print, digital and audio editions subscribe here: economist.com/thejabpod
Subscribe to our new weekly science newsletter at economist.com/simplyscience and data newsletter at www.economist.com/offthecharts
See acast.com/privacy for privacy and opt-out information.
Vaccines are helping some countries return to a semblance of normalcy, while much of the world remains vulnerable to covid-19. We explore what’s next for the pandemic at this critical juncture. Soumya Swaminathan, Chief Scientist at the World Health Organisation, says solidarity has been lacking...
Published 06/28/21
The first covid-19 vaccines came from rapid innovation. They have already saved millions of lives. What new technologies are in the pipeline?
Robin Shattock’s team at Imperial College London is developing a self-amplifying RNA vaccine.
Moz Siddiqui of Gavi, the Vaccine Alliance, describes a...
Published 06/21/21